Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Xcel Energy Inc (XEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Xcel Energy Inc — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while Xcel Energy Inc trades at $73.78 (market cap $45.82B). The key difference: Xcel Energy Inc is far larger — about 7.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and Xcel Energy Inc pays a 3.23% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Xcel Energy Inc for 61 Days on average.
| IOVA | XEL | |
|---|---|---|
Market Cap | $6.04B | $45.82B |
Volume | 14,805,993 | 6,910,516 |
Sector | Health | Utilities |
52-Week High | $14.82 | $83.91 |
52-Week Low | $1.81 | $69.39 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $5.97B | $84.14B |
Dividend Yield | — | 3.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Xcel Energy (XEL) trades at $73.78, up 1.87% with bullish technical signals and strong institutional support. The stock shows solid fundamentals with $14.67B revenue, 15.28% net margin, and consistent earnings beats. Recent news highlights growing data center power demand and a $60B capital investment plan driving future growth. Analyst consensus remains positive with a $90.83 price target representing 23% upside potential.
XEL offers attractive total return potential through earnings growth and dividend yield, supported by regulated utility business model and infrastructure investments. Key risks include wildfire liabilities, rising interest rates impacting financing costs, and execution challenges with large capital projects. The stock presents a balanced opportunity for income and growth investors seeking utility exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
